Ventyx Biosciences, Inc. (VTYX) has 84 open-market insider trades by 12 insiders since 2021. The most active filer is John Nuss, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Somu Subramaniam | Dir10% Owner | — | 13 | $66.5M | 2026-03-04 |
| Raju Mohan | CEOPres | — | 14 | $30.9M | 2026-03-04 |
| NSV Partners III LP via Somu Subramaniam | 10% Owner | — | 4 | $23.2M | 2023-09-18 |
| Martin Auster | CFO | — | 8 | $10.4M | 2024-04-02 |
| Bihua Chen | 10% Owner | — | 1 | $10.0M | 2021-10-25 |
| John Nuss | CSO | — | 16 | $8.5M | 2026-03-04 |
| Sheila Gujrathi | Dir | — | 2 | $7.0M | 2026-03-04 |
| Christopher W. Krueger | — | — | 13 | $6.8M | 2024-04-02 |
| William J. Sandborn | — | — | 10 | $5.7M | 2023-08-31 |
| Aaron Royston | Dir10% Owner | — | 1 | $5.0M | 2021-10-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Raju Mohan | CEO & President | Sell | $731K | 2025-12-18 |
| John Nuss | CSO | Sell | $98K | 2025-12-18 |
| John Nuss | CHIEF SCIENTIFIC OFFICER | Sell | $2K | 2025-04-02 |
| John Nuss | CHIEF SCIENTIFIC OFFICER | Sell | $50K | 2024-12-27 |
| Sheila Gujrathi | Director | Buy | $300K | 2024-12-23 |
| John Nuss | CHIEF SCIENTIFIC OFFICER | Sell | $30K |
Companies that share insiders with VTYX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-12-19 |
| Raju Mohan | CEO & President | Buy | $1.9M | 2024-11-22 |
| Martin Auster | CFO | Sell | $8K | 2024-04-02 |
| Christopher W. Krueger | CHIEF BUSINESS OFFICER | Sell | $9K | 2024-04-02 |
| Raju Mohan | President | Sell | $23K | 2024-04-02 |
| Christopher W. Krueger | Chief Business Officer | Sell | $11K | 2023-12-20 |
| Raju Mohan | CEO & President | Sell | $250K | 2023-12-20 |
| John Nuss | Chief Scientific Officer | Sell | $37K | 2023-12-20 |
| Somu Subramaniam | Director & 10% Owner | Sell | $3.0M | 2023-10-09 |
| NSV Partners III GP LLC | 10% | Sell | $1.5M | 2023-10-09 |